Scientists closer to Ebola drug

2010-08-22 22:43

Paris - US scientists said on Sunday they had cleared a key hurdle in the quest for a drug to treat Ebola, a notorious African virus and feared future weapon of bioterrorism.

A treatment administered to rhesus monkeys within an hour of being infected by the deadliest strain of Ebola was 60% effective, and a companion drug was 100% effective in shielding cynomolgus monkeys against Ebola's cousin, the Marburg virus.

After studying the findings, the US Food and Drug Administration (FDA) has given the green light for trials on a small group of human volunteers, they said.

Ebola and Marburg are part of a family of so-called filoviruses, which cause haemorrhagic fever - a disease with mortality rates of up to 90% where, in some cases, the patient bleeds to death.

The drugs are in a class of compound called PMO, for phosphorodiamidate morpholino oligomers. They are designed to hamper the virus' replication in cells, thus buying time for the immune system to mount a response and crush the invader.

The research, appearing online in the journal Nature Medicine, was conducted by the US Army Medical Research Institute of Infectious Diseases in collaboration with a Washington-based biotech firm, AVI BioPharma.

The Pentagon pumped funding into research for a vaccine and treatment for Ebola-type viruses in the wake of the September 9 2001 terror attacks on the United States.

Filoviruses are on the list of pathogens such as anthrax that are considered tempting sources for biological warfare or terrorism.

An important step in combating Ebola was announced in May this year, again using tests on lab monkeys but involving a somewhat different technique to disrupt viral replication.

A team at the US National Emerging Diseases Laboratory Institute at Boston University Medical School designed drugs with small interfering RNAs, or siRNAs, which hamstring reproductive enzymes.

Despite this progress, a long road lies ahead before any treatment is licensed for humans, experts say.

Testing a prototype drug is a three-phase process that starts with a tiny group of volunteers, where it is initially assessed for safety, and then broadens out to successively bigger groups, where effectiveness becomes a parallel question.

According to the UN's World Health Organisation (WHO), about 1 850 cases of Ebola, with some 1 200 deaths, have occurred since 1976.

The virus has a natural reservoir in several species of African fruit bat.

Gorillas and other non-human primates are also susceptible to the disease.

Read more on:    us  |  health  |  research
NEXT ON NEWS24X

linking and moving

2015-04-22 07:36

SHARE:

Read News24’s Comments Policy

Inside News24

 
/News
 

Road Accident Fund: #Takecharge to make roads safer

Hot on the heels of its Easter meet the #FutureYou campaign, the Road Accident Fund (RAF) will once again take its road safety message to the public - Sponsored.

 
 

Stay safe

Juvenile pillion riders? Play safe...
First-aid kit: What you need in YOUR car
Hey, lazy! Get outta the disabled bay!
Yaris: Perfect car for back-seat babes
Horoscopes
Aquarius
Aquarius

The pressure is on to perform, but you may not feel emotionally prepared. The most important thing is not to place your...read more

There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.